Cancer epidemiology 50 years later

Mettlin, Curtis

doi:10.1002/(sici)1097-0142(19981001)83:7<1275::aid-cncr1>3.0.co;2-i

Cited by 2 publications

(2 citation statements)

References 5 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The introduction of PSA testing in the late 1980s and its expanded utilization in the 1990s is credited with the increased early detection and "stage shift" toward early-stage, potentially curable disease at diagnosis (Burack & Wood, 1999;Mettlin, 1998;Mettlin & Murphy, 1998;Mettlin, Murphy, Babaian, et al, 1997). PSA screening also has been credited for recent declines in mortality (Mettlin, 1998;Mettlin & Murphy, 1998), although this assertion is a subject of debate and further investigation. Whereas controlled studies are currently under way to determine whether screening with PSA test and DRE reduces overall mortality, epidemiologic evidence suggests that PSA screening is effective in the early detection of clinically significant prostate cancer.…”

Section: > Screening Guidelinesmentioning

confidence: 99%

Prostate Cancer Screening Decision Making Under Controversy: Implications for Health Promotion Practice

Gwede

McDermott

2006

Health Promotion Practice

View full text Add to dashboard Cite

Prostate cancer is a major health problem for U.S. men and is characterized by paradoxes and controversies. Despite the wide availability of the prostate-specific antigen (PSA) test, prostate cancer screening remains a controversial practice mainly because the direct impact of screening on mortality is not yet proven. As the relative value of screening, early detection, and treatment strategies continue to be debated, glaring racial-ethnic disparities persist with African American men experiencing excess morbidity and mortality and demonstrating the lowest screening rates among racial-ethnic groups. Given the prevailing controversy, uncertainty, and known disparities, how can health education messages be framed to assist men and their family members? This article highlights the ethnic disparities, paradoxes, and controversies of prostate cancer and identifies critical challenges and opportunities for health educators and clinical practitioners. Implications for health promotion communications and informed decision making in this era of uncertainty are discussed.

show abstract

Section: > Screening Guidelinesmentioning

confidence: 99%

Prostate Cancer Screening Decision Making Under Controversy: Implications for Health Promotion Practice

Gwede

McDermott

2006

Health Promotion Practice

View full text Add to dashboard Cite

show abstract

“…Proponents of routine screening have pointed to recent declines in prostate cancer mortality as evidence of the benefits of routine screening, early detection, and early treatment (Mettlin, 1998;Mettlin & Murphy, 1998). There is growing consensus that as we await evidence from controlled trials, all men including those at high risk, must be counseled with balanced information that discusses both the potential benefits and harms of testing to make an informed decision about whether to be tested or not (ACS, 2008;Lin et al, 2008;USPSTF, 2002USPSTF, , 2008.…”

Section: Introductionmentioning

confidence: 99%

Is Social Support From Family Associated With PSA Testing? An Exploratory Analysis Using the Health Information National Trends Survey (HINTS) 2005

et al. 2008

View full text Add to dashboard Cite

African American and White men have the highest rates of prostate cancer in the United States. Families represent important social contexts within which illness occurs. The purpose of this study is to explore whether prostate-specific antigen (PSA) testing is associated with instrumental and informational social support from family members among a sample of Black and White men aged 45 and older. Data from the 2005 Health Information National Trends Survey were analyzed using logistic regression. The dependent variable was having a PSA test within the past year or less. The independent variables consisted of selected demographic and family informational and instrumental social support variables. The statistically significant variables included age and having a family member with cancer. Additional studies to elucidate the mechanisms of social support from family for prostate cancer are needed.

show abstract

Cancer epidemiology 50 years later

Cited by 2 publications

References 5 publications

Prostate Cancer Screening Decision Making Under Controversy: Implications for Health Promotion Practice

Prostate Cancer Screening Decision Making Under Controversy: Implications for Health Promotion Practice

Is Social Support From Family Associated With PSA Testing? An Exploratory Analysis Using the Health Information National Trends Survey (HINTS) 2005

Contact Info

Product

Resources

About